INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 432m ago
HOUSE PTR32m ago
SEC 13F32m ago
ROBINHOOD CHAIN32m ago
SEC FORM 4/Grant or awardVerified data

Bardin Stephen reported CALC

Chief Financial Officer · CalciMedica, Inc. · CalciMedica, Inc. — Employee Stock Option (Right to Buy)

Side
A
Value
—
Shares
67.7K
Price
—
Executed
Apr 5, 2025
Disclosed
Apr 7, 2026
Disclosure timeline367 days from execution to publication · legal deadline 2 business days
Apr 5 executedApr 7, 2026 disclosed

CALC · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
24/ 100 · ROUTINE
Methodology →
  • Transaction type0 / 20

    Grant or award — administrative, little informational value

  • Relative size+1 / 25

    No reported dollar value · new position

  • Filing timing+15 / 15

    Disclosed 262 business days after execution (deadline: 2)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · CALC

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    9
    RW
    Roberts Eric WDirector, CHIEF BUSINESS OFFICER
    CALCCalciMedica, Inc.
    Grant or award
    		A—
    180.0K sh
    		Nov 3, 2026Nov 5, 2026
    traded Nov 3, 2026
    		+2dSEC FORM 4

    Evidence

    9
    HS
    Hebbar SudarshanChief Medical Officer
    CALCCalciMedica, Inc.
    Grant or award
    		A—
    180.0K sh
    		Sep 24, 2026Sep 28, 2026
    traded Sep 24, 2026
    		+4dSEC FORM 4

    Evidence

    9
    BS
    Bardin StephenChief Financial Officer
    CALCCalciMedica, Inc.
    Grant or award
    		A—
    190.0K sh
    		Sep 24, 2026Sep 28, 2026
    traded Sep 24, 2026
    		+4dSEC FORM 4

    Evidence

    9
    SA
    Stauderman Kenneth A.Chief Scientific Officer
    CALCCalciMedica, Inc.
    Grant or award
    		A—
    180.0K sh
    		Sep 24, 2026Sep 28, 2026
    traded Sep 24, 2026
    		+4dSEC FORM 4

    Evidence

    9
    GA
    Glicklich AlanDirector
    CALCCalciMedica, Inc.
    Grant or award
    		A—
    10.0K sh
    		Aug 19, 2026Aug 21, 2026
    traded Aug 19, 2026
    		+2dSEC FORM 4

    Evidence

    9
    HS
    Hebbar SudarshanChief Medical Officer
    CALCCalciMedica, Inc.
    Grant or award
    		A—
    124.5K sh
    		Aug 19, 2026Aug 21, 2026
    traded Aug 19, 2026
    		+2dSEC FORM 4

    Evidence

    9
    GF
    Guerard FredericDirector
    CALCCalciMedica, Inc.
    Grant or award
    		A—
    10.0K sh
    		Aug 19, 2026Aug 21, 2026
    traded Aug 19, 2026
    		+2dSEC FORM 4

    Evidence

    9
    HS
    Hebbar SudarshanChief Medical Officer
    CALCCalciMedica, Inc.
    Grant or award
    		A—
    124.5K sh
    		Aug 19, 2026Aug 21, 2026
    traded Aug 19, 2026
    		+2dSEC FORM 4

    Evidence

    24
    HS
    Hebbar SudarshanChief Medical Officer
    CALCCalciMedica, Inc.
    Grant or award
    		A$100K
    124.5K sh
    		Jun 25, 2026Jun 29, 2026
    traded Jun 25, 2026
    		+4dSEC FORM 4

    Evidence

    24
    DJ
    Dunn Michael J.President and COO
    CALCCalciMedica, Inc.
    Grant or award
    		A—
    65.1K sh
    		Apr 5, 2025Apr 7, 2026
    traded Apr 5, 2025
    		+367dSEC FORM 4

    Evidence

    24
    HS
    Hebbar SudarshanChief Medical Officer
    CALCCalciMedica, Inc.
    Grant or award
    		A—
    91.2K sh
    		Apr 5, 2025Apr 7, 2026
    traded Apr 5, 2025
    		+367dSEC FORM 4

    Evidence

    24
    SA
    Stauderman Kenneth A.Chief Scientific Officer
    CALCCalciMedica, Inc.
    Grant or award
    		A—
    65.1K sh
    		Apr 5, 2025Apr 7, 2026
    traded Apr 5, 2025
    		+367dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0001942596-26-000002
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Apr 5, 2025
    Published
    Apr 7, 2026
    Ingested by INSIDER
    Nov 5, 04:07 UTC
    Last re-read
    Nov 5, 04:07 UTC

    Extracted facts

    Filer
    Bardin Stephen
    Role
    Chief Financial Officer
    Transaction
    Grant or awardAs filed: “A”
    Asset
    CalciMedica, Inc. — Employee Stock Option (Right to Buy)
    Ticker
    CALC
    Shares
    67.7K
    Price per share
    $0
    Execution date (reported)
    Apr 5, 2025
    Owned after transaction
    67.7K shares
    Days from execution to publication
    367

    What this establishes

    Bardin Stephen filed this Form 4 reporting a grant or award of CALC on Apr 5, 2025. It became public on Apr 7, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    Chief Financial Officer
    Bardin Stephencik:0001942596
    Issuer
    CalciMedica, Inc.cik:0001534133

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.